Serologic tests for syphilis (STS) results at time of diagnosis are the basis for evaluating response to syphilis therapy. Following treatment, however, STS titers may continue to increase for several weeks. We evaluated RPR titer variation over the 14 days following therapy using data from a recent large, prospective RCT
There has been a resurgence of syphilis diagnoses in Australia. We investigated whether ourpolymeras...
Purpose: HIV-infected patients treated for syphilis may be at increased risk for serological failure...
Background. Screening for syphilis with treponemal chemiluminescence immunoassays (CIA) identifies p...
Serologic tests for syphilis (STS) results at time of diagnosis are the basis for evaluating respons...
Syphilis management is complex and demonstration of treatment response requires monitoring of nontre...
Persistent nontreponemal titers after treatment are common among patients with early syphilis. We re...
Background. Syphilis management requires serological monitoring after therapy. We compared factors a...
Serological tests for syphilis may show varying results in association with HIV infection.Thus care ...
Background. Serology is the mainstay for syphilis diagnosis and treatment monitoring. We investigate...
Background. Serology is the mainstay for syphilis diagnosis and treatment monitoring. We investigate...
Background Syphilis remains a global public health threat and can lead to severe complications. In a...
Some syphilis patients remain in a serologically active state after the recommended therapy. We curr...
<p>Data are given as median (range), or frequencies.</p>a<p>include 13 subjects with primary syphili...
Delays in syphilis treatment may contribute to transmission. We evaluated time to treatment for symp...
Objectives The diagnosis of repeat syphilis and its followup remains challenging. We aimed to invest...
There has been a resurgence of syphilis diagnoses in Australia. We investigated whether ourpolymeras...
Purpose: HIV-infected patients treated for syphilis may be at increased risk for serological failure...
Background. Screening for syphilis with treponemal chemiluminescence immunoassays (CIA) identifies p...
Serologic tests for syphilis (STS) results at time of diagnosis are the basis for evaluating respons...
Syphilis management is complex and demonstration of treatment response requires monitoring of nontre...
Persistent nontreponemal titers after treatment are common among patients with early syphilis. We re...
Background. Syphilis management requires serological monitoring after therapy. We compared factors a...
Serological tests for syphilis may show varying results in association with HIV infection.Thus care ...
Background. Serology is the mainstay for syphilis diagnosis and treatment monitoring. We investigate...
Background. Serology is the mainstay for syphilis diagnosis and treatment monitoring. We investigate...
Background Syphilis remains a global public health threat and can lead to severe complications. In a...
Some syphilis patients remain in a serologically active state after the recommended therapy. We curr...
<p>Data are given as median (range), or frequencies.</p>a<p>include 13 subjects with primary syphili...
Delays in syphilis treatment may contribute to transmission. We evaluated time to treatment for symp...
Objectives The diagnosis of repeat syphilis and its followup remains challenging. We aimed to invest...
There has been a resurgence of syphilis diagnoses in Australia. We investigated whether ourpolymeras...
Purpose: HIV-infected patients treated for syphilis may be at increased risk for serological failure...
Background. Screening for syphilis with treponemal chemiluminescence immunoassays (CIA) identifies p...